Zobrazeno 41 - 50
of 522
pro vyhledávání: '"Robert A. Anders"'
Autor:
Jacquelyn W. Zimmerman, Elizabeth M. Jaffee, Todd D. Armstrong, Aleksandra Popovic, Bridget P. Keenan, Alexander C. Hopkins, Minwei Cao, Elana J. Fertig, Robert A. Anders, Nina J. Chu
R script of TCGA computational analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7058146a7ad07ea6bc16860e6af9b3
https://doi.org/10.1158/1940-6207.22534760
https://doi.org/10.1158/1940-6207.22534760
Autor:
Cynthia L. Sears, Franck Housseau, Heather M. O'Hagan, Stephen B. Baylin, Robert A. Anders, Sepideh Besharati, Angelo M. De Marzo, Hao Wang, Douglas B. Rusch, Ram Podicheti, Shruthi Sriramkumar, Ashley R. Maiuri, John Michel, Hongni Fan, Christine M. Dejea, June L. Chan, Ada J. Tam, Jessica L. Hicks, Alyssa Wenzel, Liam Chung, James R. White, Christina E. DeStefano Shields
Supplementary Figures 1-6; Table S4: Tumors from ETBF-colonized BRAFV600ELgr5CreMin (BLM) mice are MSI negative; Table S6: Primer sequences for qMSP and assays used for Taqman gene expression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836113c42e53c55422cc9c54f512311b
https://doi.org/10.1158/2159-8290.22540276
https://doi.org/10.1158/2159-8290.22540276
Autor:
Janis M. Taube, Drew M. Pardoll, Suzanne L Topalian, Hao Wang, Brandon S. Luber, Shuming Chen, Katie Beierl, Jung H. Kim, Haiying Xu, Ming-Tseh Lin, James R. Eshleman, Robert A. Anders, Nemanja Rodić
PD-L1 expression in melanoma correlates with response to PD-1 pathway–blocking antibodies. Aberrant tumor-cell PD-L1 expression may be oncogene driven and/or induced by IFNγ. Melanomas express PD-L1 in association with tumor-infiltrating lymphocyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1645bf4a9692b669078c6c47ef8a5bd4
https://doi.org/10.1158/2326-6066.c.6548855
https://doi.org/10.1158/2326-6066.c.6548855
Autor:
Robert A. Anders, Elizabeth M. Jaffee, Akhilesh Pandey, Daniel A. Laheru, Dung T. Le, Lei Zheng, Alison P. Klein, Rajni Sharma, Lanqing Huang, Elizabeth D. Thompson, Min-Sik Kim, Darshil T. Jhaveri
Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States. Less than 6% of patients survive beyond the fifth year due to inadequate early diagnostics and ineffective treatment options. Our laboratory has developed an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2473fe3666c7aba6297b4bed7b08f2b
https://doi.org/10.1158/2326-6066.c.6548429.v1
https://doi.org/10.1158/2326-6066.c.6548429.v1
Autor:
Lei Zheng, Elizabeth M. Jaffee, Robert A. Anders, Ralph H. Hruban, Jiang Wang, Christopher L. Wolfgang, Daniel Laheru, Allison Yager, Anthony Wamwea, Alvin Dorman, Sara Solt, Kevin Soares, Guanglan Mo, Rajni Sharma, Elaine Bigelow, Annie A. Wu, Eric R. Lutz
Figure S1 Schema of the Neoadjuvant and Adjuvant Study of Panc GVAX. Figure S2 Pre- and post-vaccination mesothelin peptide-specific T cell levels in responders versus nonresponders. Figure S3 Intratumoral tertiary lymphoid aggregate in PDACs from pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c73b3a7e2bb6ff97dd06f2450b7f14fe
https://doi.org/10.1158/2326-6066.22537381.v1
https://doi.org/10.1158/2326-6066.22537381.v1
Autor:
Charles G. Drake, Drew M. Pardoll, Robert A. Anders, Alan K. Meeker, Muniza Uddin, Christopher J. Thoburn, Ada J. Tam, Esteban Velarde, Ariel E. Marciscano, Ali Ghasemzadeh, Maria A. Carrera-Haro, Wendy Mao, Debebe Theodros, Zoila Lopez-Bujanda, Christina M. Kochel, Thomas R. Nirschl, Yuki Muroyama
Supplementary Figure 1: Radiotherapy suppresses tumor growth. Supplementary Figure 2: Characterization of the TME of B16/F10 tumors post-RT. Supplementary Figure 3: Stereotactic radiation does not change Treg in draining lymph nodes nor in spleens of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59d0daf2f601e79ccd1c1be73f87bf61
https://doi.org/10.1158/2326-6066.22535884.v1
https://doi.org/10.1158/2326-6066.22535884.v1
Autor:
Jacquelyn W. Zimmerman, Elizabeth M. Jaffee, Todd D. Armstrong, Aleksandra Popovic, Bridget P. Keenan, Alexander C. Hopkins, Minwei Cao, Elana J. Fertig, Robert A. Anders, Nina J. Chu
Supplementary text
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ddd0c26182bb945fc3810b92cd0dfc5
https://doi.org/10.1158/1940-6207.22534754
https://doi.org/10.1158/1940-6207.22534754
Autor:
Robert A. Anders, Elizabeth M. Jaffee, Akhilesh Pandey, Daniel A. Laheru, Dung T. Le, Lei Zheng, Alison P. Klein, Rajni Sharma, Lanqing Huang, Elizabeth D. Thompson, Min-Sik Kim, Darshil T. Jhaveri
Venn diagram showing overlap of proteins identified in 3 patients after the SASI screen.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9956ca0e5d75d8256ddbb06646a643e2
https://doi.org/10.1158/2326-6066.22537406.v1
https://doi.org/10.1158/2326-6066.22537406.v1
Autor:
Cynthia L. Sears, Franck Housseau, Heather M. O'Hagan, Stephen B. Baylin, Robert A. Anders, Sepideh Besharati, Angelo M. De Marzo, Hao Wang, Douglas B. Rusch, Ram Podicheti, Shruthi Sriramkumar, Ashley R. Maiuri, John Michel, Hongni Fan, Christine M. Dejea, June L. Chan, Ada J. Tam, Jessica L. Hicks, Alyssa Wenzel, Liam Chung, James R. White, Christina E. DeStefano Shields
Colorectal cancer is multifaceted, with subtypes defined by genetic, histologic, and immunologic features that are potentially influenced by inflammation, mutagens, and/or microbiota. Colorectal cancers with activating mutations in BRAF are associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1a526c0fa8ded8e7a89042195bc05ed
https://doi.org/10.1158/2159-8290.c.6549334
https://doi.org/10.1158/2159-8290.c.6549334
Autor:
Lei Zheng, Elizabeth M. Jaffee, Robert A. Anders, Rajni Sharma, Jennifer Kleponis, Xu Che, Jianlin Chen, Stephen Muth, Qian Xiao, Agnieszka A. Rucki
Supplementary Figure 1. The rate of proliferation is the same in the orthotopic and transgenic KPC mouse models Supplementary Figure 2. Single c-Met or Hh inhibitor treatment leads to the enhanced expression of the other target and the combination of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51af8504464b3cf1cf41659cdc0207fd
https://doi.org/10.1158/1535-7163.22507588
https://doi.org/10.1158/1535-7163.22507588